0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-03-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 11820993 2023-03-01 2024-02-29 11820993 2024-02-29 11820993 2023-02-28 11820993 2022-03-01 2023-02-28 11820993 2023-02-28 11820993 2022-02-28 11820993 bus:Director1 2023-03-01 2024-02-29 11820993 core:WithinOneYear 2024-02-29 11820993 core:WithinOneYear 2023-02-28 11820993 core:ShareCapital 2024-02-29 11820993 core:ShareCapital 2023-02-28 11820993 core:RetainedEarningsAccumulatedLosses 2024-02-29 11820993 core:RetainedEarningsAccumulatedLosses 2023-02-28 11820993 bus:SmallEntities 2023-03-01 2024-02-29 11820993 bus:AuditExemptWithAccountantsReport 2023-03-01 2024-02-29 11820993 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 11820993 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 11820993 bus:AbridgedAccounts 2023-03-01 2024-02-29
COMPANY REGISTRATION NUMBER: 11820993
Kynd Clinic Ltd
Filleted Unaudited Abridged Financial Statements
29 February 2024
Kynd Clinic Ltd
Abridged Financial Statements
Year ended 29 February 2024
Contents
Page
Abridged statement of financial position
1
Notes to the abridged financial statements
3
Kynd Clinic Ltd
Abridged Statement of Financial Position
29 February 2024
2024
2023
Note
£
£
Current assets
Debtors
8,792
7,069
Cash at bank and in hand
176
3,612
-------
--------
8,968
10,681
Creditors: amounts falling due within one year
10,313
10,314
--------
--------
Net current (liabilities)/assets
( 1,345)
367
-------
----
Total assets less current liabilities
( 1,345)
367
-------
----
Net (liabilities)/assets
( 1,345)
367
-------
----
Capital and reserves
Called up share capital
100
100
Profit and loss account
( 1,445)
267
-------
----
Shareholders (deficit)/funds
( 1,345)
367
-------
----
These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of income and retained earnings has not been delivered.
For the year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its abridged financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements .
All of the members have consented to the preparation of the abridged statement of income and retained earnings and the abridged statement of financial position for the year ending 29 February 2024 in accordance with Section 444(2A) of the Companies Act 2006.
Kynd Clinic Ltd
Abridged Statement of Financial Position (continued)
29 February 2024
These abridged financial statements were approved by the board of directors and authorised for issue on 27 November 2024 , and are signed on behalf of the board by:
Mr F Jafari
Director
Company registration number: 11820993
Kynd Clinic Ltd
Notes to the Abridged Financial Statements
Year ended 29 February 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 151 Askew Road, London, W12 9AU.
2. Statement of compliance
These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The abridged financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship (see hedge accounting policy). Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Director's advances, credits and guarantees
At the year end Mr J Farzam owed the company £8,792 (2023: £7,069) in non interest bearing loan.